Gender differences in patients with structural heart disease undergoing VT ablation
Open Access
- 19 August 2021
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (10) , 2675-2683
Abstract
Introduction: This study sought to examine gender differences in patients with structural heart disease (SHD) referred for ablation of ventricular tachycardia (VT).Background: Female patients are often underrepresented in large studies. Significant differences in the clinical presentation, treatment, and prognosis of female patients have been described in previous studies.Methods and Results: We investigated 88 female patients with SHD undergoing VT ablation (mean age 59 years, 56% nonischemic cardiomyopathy, mean left ventricular ejection fraction 35%, 82% in electrical storm). A case‐control study with 88 male patients was performed and the results regarding clinical and procedural characteristics, acute and long‐term results of the two groups were compared. The female patients had more arrhythmogenic substrate, as they more commonly presented with electrical storm (p = .016) and had a higher number of inducible VT morphologies during the procedure (p = .018). Moreover, the female patients were less likely to have an optimized heart failure medical treatment at baseline (p = .030) and required more time from the first manifestation of the VT to ablation referral (p = .034). Although fewer epicardial ablations were performed in female patients (p = .019), the two groups showed similar results regarding VT noninducibility as ablation endpoint (p = .844), major procedure‐related complications (p = .719) and freedom from VT during follow‐up (p = .268). Moreover, the overall mortality in the two groups was similar (p = .176). Advanced NYHA class was associated with worse transplant and assist‐device‐free survival in the female group.Conclusion: Female patients presenting for VT ablation had more arrhythmogenic substrate and were less likely to have an optimized heart failure medical treatment. Nevertheless, the procedural acute and long‐term outcomes between the two genders were similar.Keywords
This publication has 25 references indexed in Scilit:
- Sex and gender influences on pharmacological response: an overviewExpert Review of Clinical Pharmacology, 2014
- Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and womenBritish Journal of Pharmacology, 2014
- Outcome of Invasive Electrophysiological Procedures and Gender: Are Males and Females the Same?Journal of Cardiovascular Electrophysiology, 2010
- Outcomes and complications of catheter ablation for atrial fibrillation in femalesHeart Rhythm, 2010
- Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trialThe Lancet, 2010
- Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial InfarctionCirculation, 2008
- More Reasons Why Men and Women Are Not the Same (Gender Differences in Electrophysiology and Arrhythmias)The American Journal of Cardiology, 2008
- Prophylactic Catheter Ablation for the Prevention of Defibrillator TherapyNew England Journal of Medicine, 2007
- Sex-specific triggers for right ventricular outflow tract tachycardiaAmerican Heart Journal, 2000
- Cyclical variation in paroxysmal supraventricular tachycardia in womenThe Lancet, 1996